Gibot S - Search Results

1

Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.

Barnay-Verdier S, Fattoum L, Borde C, Kaveri S, Gibot S, Maréchal V. Barnay-Verdier S, et al. Among authors: gibot s. Intensive Care Med. 2011 Jun;37(6):957-62. doi: 10.1007/s00134-011-2192-6. Epub 2011 Feb 26. Intensive Care Med. 2011. PMID: 21359606

2

Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock.

Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Béné MC, Faure GC, Lévy B. Gibot S, et al. Intensive Care Med. 2005 Apr;31(4):594-7. doi: 10.1007/s00134-005-2572-x. Epub 2005 Mar 8. Intensive Care Med. 2005. PMID: 15754199

3

Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock.

Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P. Levy B, et al. Among authors: gibot s. Intensive Care Med. 2007 Mar;33(3):495-502. doi: 10.1007/s00134-006-0523-9. Epub 2007 Jan 23. Intensive Care Med. 2007. PMID: 17242933

4

High-mobility group box 1 protein plasma concentrations during septic shock.

Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE. Gibot S, et al. Intensive Care Med. 2007 Aug;33(8):1347-53. doi: 10.1007/s00134-007-0691-2. Epub 2007 May 25. Intensive Care Med. 2007. PMID: 17525840

5

Increased muscle-to-serum lactate gradient predicts progression towards septic shock in septic patients.

Levy B, Perez P, Gibot S, Gerard A. Levy B, et al. Among authors: gibot s. Intensive Care Med. 2010 Oct;36(10):1703-1709. doi: 10.1007/s00134-010-1938-x. Epub 2010 Jun 25. Intensive Care Med. 2010. PMID: 20577713

6

PCA-ELISA: a sensitive method to quantify free and masked forms of HMGB1.

Barnay-Verdier S, Gaillard C, Messmer M, Borde C, Gibot S, Maréchal V. Barnay-Verdier S, et al. Among authors: gibot s. Cytokine. 2011 Jul;55(1):4-7. doi: 10.1016/j.cyto.2011.03.011. Epub 2011 Apr 6. Cytokine. 2011. PMID: 21474328

7

Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock.

Bouazza Y, Sennoun N, Strub C, Regnault V, Gibot S, Meziani F, Lacolley P, Levy B. Bouazza Y, et al. Among authors: gibot s. Intensive Care Med. 2011 Nov;37(11):1857-64. doi: 10.1007/s00134-011-2327-9. Epub 2011 Aug 18. Intensive Care Med. 2011. PMID: 21850534

8

Is Thrombocytopenia an Early Prognostic Marker in Septic Shock?

Thiery-Antier N, Binquet C, Vinault S, Meziani F, Boisramé-Helms J, Quenot JP; EPIdemiology of Septic Shock Group. Thiery-Antier N, et al. Crit Care Med. 2016 Apr;44(4):764-72. doi: 10.1097/CCM.0000000000001520. Crit Care Med. 2016. PMID: 26670473

9

Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock.

Barnay-Verdier S, Borde C, Fattoum L, Wootla B, Lacroix-Desmazes S, Kaveri S, Gibot S, Maréchal V. Barnay-Verdier S, et al. Among authors: gibot s. Cell Immunol. 2020 Jan;347:104020. doi: 10.1016/j.cellimm.2019.104020. Epub 2019 Nov 15. Cell Immunol. 2020. PMID: 31767118 Free article.

10

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial.

François B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Pickkers P, Vandenhende F, Garaud JJ, Sánchez M, Salcedo-Magguilli M, Laterre PF. François B, et al. Among authors: gibot s. Intensive Care Med. 2020 Jul;46(7):1425-1437. doi: 10.1007/s00134-020-06109-z. Epub 2020 May 28. Intensive Care Med. 2020. PMID: 32468087 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page